We are live on ! Find out more
RC

Rangeley Capital Portfolio holdings

AUM $103M
1-Year Est. Return 77.32%
This Fund
S&P 500
This Quarter Est. Return
-3.19%
1 Year Est. Return
+77.32%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$103M
AUM Growth
-$17.5M
Cap. Flow
-$2.25M
Cap. Flow %
-2.19%
Top 10 Hldgs %
35.28%
Holding
169
New
46
Increased
35
Reduced
35
Closed
32

Top Buys

Rank Stock Value
1
DRVN icon
Driven Brands
DRVN
+$8.81M
2
RVMD icon
Revolution Medicines
RVMD
+$6.74M
3
ICLR icon
Icon
ICLR
+$2.42M
4
TRIP icon
TripAdvisor
TRIP
+$2.21M
5
ELME
Elme Communities
ELME
+$2.17M

Top Sells

Rank Stock Value
1
GDEN
Golden Entertainment
GDEN
+$5.71M
2
CLMT icon
Calumet Specialty Products
CLMT
+$5.34M
3
WBD icon
Warner Bros
WBD
+$4.62M
4
RNAM
Avidity Biosciences
RNAM
+$3.9M
5
RPTX
Repare Therapeutics
RPTX
+$3.35M

Sector Composition

Rank Sector Weight
1 Healthcare 29.22%
2 Consumer Discretionary 17.78%
3 Real Estate 12.14%
4 Financials 8.26%
5 Technology 4.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VYNE icon
126
VYNE Therapeutics
VYNE
$19.1M
$70.5K 0.07%
2,361
+361
+18% +$10.5K
TASK icon
127
TaskUs
TASK
$531M
$67.1K 0.07%
10,000
– –
MGNX icon
128
MacroGenics
MGNX
$254M
$62.1K 0.06%
21,500
-8,720
-29% -$18.6K
IVVD icon
129
Invivyd
IVVD
$180M
$58.5K 0.06%
+45,000
New +$82.6K
BUR icon
130
Burford Capital
BUR
$922M
$52.3K 0.05%
11,569
-46,431
-80% -$406K
GECC icon
131
Great Elm Capital Corp
GECC
$71.4M
$50.1K 0.05%
+10,000
New +$62.7K
LAB icon
132
Standard BioTools
LAB
$303M
$46K 0.04%
+50,000
New +$60.5K
CCO icon
133
Clear Channel Outdoor Holdings
CCO
$1.23B
$44.1K 0.04%
+18,600
New +$42.1K
AIFC
134
AI Financial Corp
AIFC
$55.6M
$28.9K 0.03%
26,000
-3,000
-10% -$4.89K
ALIT icon
135
Alight
ALIT
$520M
$28.8K 0.03%
+2,473
New +$58.9K
KPRX icon
136
Kiora Pharmaceuticals
KPRX
$11.3M
$19.3K 0.02%
+10,000
New +$21.1K
XRX icon
137
Xerox
XRX
$357M
$9.05K 0.01%
+100,000
New +$198K
ANEB
138
DELISTED
Anebulo Pharmaceuticals
ANEB
– –
-50,000
Closed -$50.5K
ANTX icon
139
AN2 Therapeutics
ANTX
$178M
– –
-65,000
Closed -$74.1K
AVDL
140
DELISTED
Avadel Pharmaceuticals
AVDL
– –
-75,953
Closed -$1.64M
BBIO icon
141
CALL
BridgeBio Pharma
BBIO
$16.5B
– –
-5,000
Closed -$382K
BHF icon
142
CALL
Brighthouse Financial
BHF
$3.63B
– –
-4,300
Closed -$279K
BHR.PRB
143
Braemar Hotels & Resorts 5.50% Series B Preferred Stock
BHR.PRB
$53.1M
– –
-17,245
Closed -$255K
CORZ icon
144
Core Scientific
CORZ
$6.59B
– –
-10,000
Closed -$146K
FONR
145
DELISTED
Fonar
FONR
– –
-25,113
Closed -$466K
GBIO
146
DELISTED
Generation Bio
GBIO
– –
-98,280
Closed -$558K
GDEN
147
DELISTED
Golden Entertainment
GDEN
– –
-209,881
Closed -$5.71M
IWM icon
148
PUT
iShares Russell 2000 ETF
IWM
$80.3B
– –
-5,000
Closed -$1.23M
KORE
149
DELISTED
KORE Group Holdings
KORE
– –
-131,347
Closed -$554K
MRSN
150
DELISTED
Mersana Therapeutics
MRSN
– –
-57,098
Closed -$1.65M
3 4 5
6
7

Similar funds

EFT
Envision Financial Transparency Greensboro, North Carolina $103M AUM
GWL
Generations Wealth LLC Mason, Ohio $103M AUM
CC
Caspian Capital New York $103M AUM
ABLA
Alan B. Lancz & Associates Toledo, Ohio $103M AUM 31.99% 1-Year Est. Return
SPCM
Stoic Point Capital Management Palo Alto, California $103M AUM
OPAM
Olympus Peak Asset Management Greenwich, Connecticut $103M AUM 58.06% 1-Year Est. Return
ES
ETF Store Overland Park, Kansas $103M AUM 15.78% 1-Year Est. Return
IMT
Investment Management Trust Fitchburg, Massachusetts $103M AUM

Rangeley Capital's Q1 2026 Portfolio in Review

As of Q1 2026, Rangeley Capital held 169 positions worth $103M, down 15% from $120M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Rangeley Capital's Q1 2026 filing shows 46 new, 35 increased, 35 reduced and 32 closed positions. Its largest new stake was Driven Brands: 625,500 shares worth $7.89M. The largest sale was Golden Entertainment, an estimated $5.71M.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, down from 33% a quarter earlier, followed by Consumer Discretionary and Real Estate.

  • Rangeley Capital's largest Q1 2026 buy was Driven Brands: 625,500 shares worth $7.89M.
  • Rangeley Capital added most to Janux Therapeutics in Q1 2026, an estimated $1.33M increase.
  • Rangeley Capital's biggest Q1 2026 reduction was Calumet Specialty Products, cutting an estimated $5.34M.
  • Rangeley Capital fully exited Golden Entertainment in Q1 2026, selling an estimated $5.71M.
  • Rangeley Capital's ten largest holdings make up 35% of its $103M portfolio in Q1 2026.
  • Rangeley Capital opened 46 new positions and closed 32 in Q1 2026.
  • Rangeley Capital's portfolio value fell 15% quarter-over-quarter to $103M.

Based on Rangeley Capital's 13F filing for Q1 2026, filed 15 May 2026.